Cord blood infusions for children with brain injuries
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial offers children with brain injuries, such as cerebral palsy or stroke, an infusion of cord blood cells that may help repair damaged brain tissue. It uses the child's own stored cord blood, a sibling's, or a matched donor's, depending on availability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age: birth to 26 years (autologous), or 6 months to 26 years (sibling/donor)
- You must have a brain injury like cerebral palsy, stroke, or a lack of oxygen to the brain
- For unrelated donor, the child must be able to walk with some difficulty (GMFCS level I-IV)
- Your child must have healthy blood counts and no active infections or immune system problems
- A stored cord blood unit that meets safety standards must be available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether infusing human umbilical cord blood can help children with cerebral palsy. It is a Phase 1 study for children whose motor problems are stable and not getting worse.
This trial tests whether an IV infusion of lab-grown stem cells from donated umbilical cord is safe for people with cerebral palsy. It mainly focuses on side effects and safety rather than proving it works.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
This Phase 2 trial studies using a cord blood transplant after finding it is risky enough that standard treatment may not be sufficient. It may help certain children and young adults with specific leukemia, lymphoma, and some non-cancer blood/immune or inherited disorders who do not have a well-matched donor available in time.
This trial tests whether transplanting cells from a child's own bone marrow, combined with rehabilitation therapy, can improve movement and function in young children with cerebral palsy caused by birth-related brain injury or bleeding. The goal is to see if this approach helps children move better and become more independent.
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
Hear when a new Cerebral Palsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.